Monoclonal Antibody Therapy at DHCHD
Currently, DHCHD is not able to get more monoclonal antibody treatments. We have requested an allocation from the state.
DHCHD will update the community when we receive another allocation and the plan to distribute treatments to those who medically qualify, and receive an order from their provider.
The FDA authorized the use of these monoclonal antibody therapies to treat mild-to-moderate COVID-19 in adults and pediatric patients when both of these apply:
- The patient has a positive COVID-19 test result
- The patient is at high risk for progressing to severe COVID-19, hospitalization, or both
Please contact your healthcare provider with questions.